About this trial
The purpose of this investigation is to identify the potentially crucial role of anticipatory reward mechanisms maintaining bulimic behavior (i.e., binge eating and purging) in bulimia nervosa (BN). The research will investigate neural and psychological anticipatory processes in BN, both in the scanner and the natural environment.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Right-handed
Ability to read and speak in English
Eating Disorder Examination (EDE) diagnosis of BN (i.e., at least one objective bulimic episode and one self-induced vomiting episode per week for at three months) with binge episodes always accompanied by self-induced vomiting
Stable dose for at least 6 weeks of any recent changes in medication impacting mood, appetite, or weight
Disqualifiers
History of gastric bypass surgery
Medical condition acutely affecting eating behavior and/or weight (i.e., pregnancy, lactation, thyroid disease)
Current medical or psychiatric instability (i.e., hospitalization required in the past three months)
Lifetime history of psychosis or bipolar disorder
Trial population
Adults with or without bulimia nervosa
Trial design
Case-control
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The Positive and Negative Affect Schedule (PANAS) self-reported negative affect
The Positive and Negative Affect Schedule (PANAS) is a self-report measure comprising two scales, one of which we will use to assess participants' negative affect. The scale includes ten Likert-style items, which participants rate from 1 = not at all to 5 = very much. Composite scores range from 10-50, and a score of 50 indicates greater negative affect. The PANAS will be administered to measure emotion at multiple times during the second visit as well as during EMA administration and to establish a baseline at the first visit.
The Positive and Negative Affect Schedule (PANAS) self-reported positive affect
The Positive and Negative Affect Schedule (PANAS) is a self-report measure comprising two scales, one of which we will use to assess participants' positive affect. The scale includes ten Likert-style items, which participants rate from 1 = not at all to 5 = very much. Composite scores range from 10-50, and a score of 50 indicates greater positive affect. The PANAS will be administered to measure emotion at multiple times during the second visit as well as during EMA administration and to establish a baseline at the first visit.
Activation in regions of the limbic threat network
fMRI will be used to assess the neural correlates of bulimic behavior anticipation. Outcome is reported as the mean z-scores from voxels in limbic regions (amygdala, hippocampus, insula) extracted from a 2x2 analysis of the BED versus HC groups in the food choice versus shopping contrast results of the fMRI task regression analysis.
Activation in regions of the striatal approach network
fMRI will be used to assess the neural correlates of bulimic behavior anticipation. Outcome is reported as the mean z-scores from voxels in striatal regions (nucleus accumbens, caudate and putamen) extracted from a 2x2 analysis of the BED versus HC groups the food choice versus shopping contrast results of the fMRI task regression analysis.
Secondary outcomes
Duration of illness
Outcome is reported as the number of days participants in the bulimia nervosa group experience illness.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.